This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Lindholt, J. S. et al. Five-year outcomes of the Danish cardiovascular screening (DANCAVAS) trial. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2208681 (2022)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fernández-Ruiz, I. CVD screening trial in older men misses primary end point but suggests benefits. Nat Rev Cardiol 19, 722 (2022). https://doi.org/10.1038/s41569-022-00781-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41569-022-00781-y